Hypothesis validation of rosiglitazone a potential inhibitor against glycogen synthase kinase-3beta, for the management of multifaceted pathophysiology of the diabetic wound: An insilico study.
Diabetic wound (DW) is a major complication of diabetes mellitus that often ends up with amputation of the concerned organ. The current therapies for DW include glucose regulation, wound debridement, pressure off-loading, surgeries, hyperbaric oxygen ther.....